Intuitive Surgical Stock Jumps. ‘Da Vinci’ Robots Guide the Future. ... marking a 17% increase from the prior year and sailing above analysts’ calls for $8.15 billion.

Intuitive Surgical reports third-quarter revenue of $2.04 billion, beating the consensus estimate of $2 billion. Intuitive Surgical reports third-quarter adjusted earnings of $1.84 per share ...

Intuitive Surgical's growth remains strong, supported by solid procedure growth and the da Vinci 5 rollout. Click here to read an analysis of ISRG stock now.

Intuitive Surgical ... the increase in ISRG stock has been far from consistent. ... Intuitive Surgical raised its projected global da Vinci procedure volume growth to 14%-17% in 2024, ...

Intuitive reported an 18% increase in procedure volume compared to last year's third quarter, ... Intuitive Surgical stock surges 10% amid da Vinci 5 demand, with full rollout set for 2025.

The robotics giant’s most advanced soft tissue surgical system is now available for use in Europe across a range of ...

Intuitive Surgical (NASDAQ: ISRG) will report its Q2 2024 results on Thursday, July 18. We expect the company’s revenues to come in at $2 billion and adjusted earnings to be $1.55 per share ...

Intuitive Surgical (NASDAQ: ISRG) builds and sells the da Vinci, a robotic system used for various surgical procedures. The company's stock has also changed lives.

For every surgical procedure performed using a da Vinci system, Intuitive generates $600 to $3,500 in instruments and accessories with its "razor-and-blade model." With this observation in mind ...

Instead, Intuitive Surgical may wait to see how the stock progresses this year -- it's already climbed about 15% since the start of January. And Intuitive Surgical has a big catalyst to keep this ...

Intuitive Surgical (Nasdaq: ISRG) announced today that it received CE mark for its da Vinci 5 surgical robotic system.